Eighty-five percent of the cases (17 out of 20) showed a more than two-fold downregulation of EEF2K mRNA in cancerous tissues as compared to the adjacent non-tumor tissues (Fig. 1a). This evidence concerns the gene EEF2K and neoplasm.